Related Experiment Video
Updated: Feb 6, 2026

Chronic Constriction Injury of the Rat's Infraorbital Nerve IoN-CCI to Study Trigeminal Neuropathic Pain
Published on: September 21, 2015
Effects of miR-26a-5p on neuropathic pain development by targeting MAPK6 in in CCI rat models
Yang Zhang1, Zhen Su1, Hai-Lin Liu1
1Department of Anesthesiology, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, 223300, PR China.
Abstract:
MicroRNA are emerging as significant regulators of neuropathic pain progression. In addition, neuroinflammation contributes a lot to neuropathic pain. miR-26a-5p has been identified as an inflammation-associated miRNA in multiple pathological processes. However, little is known about the biological role of miR-26a-5p in neuroinflammation and neuropathic pain development. Therefore, we aimed to investigate the function of miR-26a-5p in neuropathic pain by establishing a rat model using chronic sciatic nerve injury (CCI). A significant decrease of miR-26a-5p expression was observed in the spinal cord tissues form the CCI rats compared to the control group. Moreover, overexpression of miR-26a-5p significantly repressed neuropathic pain and neuroinflammation in CCI rats. MAPK6 was identified as a direct downstream target gene of miR-26a-5p and confirmed by dual-luciferase reporter assays. As displayed, overexpression of miR-26a-5p greatly reduced MAPK6 levels in vitro and in vivo. Meanwhile, MAPK6 expression and miR-26a-5p were oppositely correlated in CCI rats. Furthermore, up-regulation of MAPK6 obviously reversed the suppressive effect of miR-26a-5p on neuroinflammation and neuropathic pain progression. Taken these together, our results implied that miR-26a-5p could act as a negative regulator of neuropathic pain development through targeting MAPK6, which indicated that miR-26a-5p might serve as a potential therapeutic target for neuropathic pain.
Insights
MicroRNA-26a-5p (miR-26a-5p) levels decrease in neuropathic pain. Restoring miR-26a-5p alleviates pain and neuroinflammation by targeting MAPK6, suggesting miR-26a-5p as a potential therapeutic target.
Area of Science:
- Neuroscience
- Molecular Biology
- Pain Research
Background:
- MicroRNAs (miRNAs) are key regulators in neuropathic pain.
- Neuroinflammation significantly contributes to neuropathic pain development.
- The specific role of miR-26a-5p in neuropathic pain and neuroinflammation remains largely unexplored.
Purpose of the Study:
- To investigate the function of miR-26a-5p in neuropathic pain.
- To elucidate the underlying molecular mechanisms involving miR-26a-5p in neuroinflammation and pain progression.
Main Methods:
- Established a rat model of neuropathic pain using chronic sciatic nerve injury (CCI).
- Quantified miR-26a-5p expression in spinal cord tissues.
- Overexpressed miR-26a-5p and assessed its effects on pain behavior and neuroinflammation.
- Identified and validated MAPK6 as a direct downstream target of miR-26a-5p using dual-luciferase reporter assays.
- Examined the correlation between MAPK6 and miR-26a-5p expression in CCI rats.
- Investigated the effect of MAPK6 upregulation on miR-26a-5p's therapeutic actions.
Main Results:
- miR-26a-5p expression was significantly downregulated in the spinal cords of CCI rats compared to controls.
- Overexpression of miR-26a-5p markedly reduced neuropathic pain and neuroinflammation in CCI rats.
- MAPK6 was confirmed as a direct target of miR-26a-5p, with miR-26a-5p overexpression reducing MAPK6 levels both in vitro and in vivo.
- MAPK6 expression showed an inverse correlation with miR-26a-5p levels in CCI rats.
- Upregulation of MAPK6 reversed the beneficial effects of miR-26a-5p on neuroinflammation and neuropathic pain.
Conclusions:
- miR-26a-5p acts as a negative regulator in the development of neuropathic pain.
- The mechanism involves the direct targeting of MAPK6 by miR-26a-5p.
- miR-26a-5p presents a promising therapeutic target for managing neuropathic pain and associated neuroinflammation.
Related Concept Videos
Pain
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Analgesia and Pain Management
Framing Effects
Biological Effects of Radiation
Sustainable Development

